ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,652,583 | +75.2% | 220,553 | +67.0% | 0.02% | +83.3% |
| Q2 2023 | $11,788,408 | -21.0% | 132,083 | -5.1% | 0.01% | -25.0% |
| Q1 2023 | $14,926,740 | +4.7% | 139,216 | +19.3% | 0.02% | 0.0% |
| Q4 2022 | $14,253,060 | +50.3% | 116,704 | +27.1% | 0.02% | +45.5% |
| Q3 2022 | $9,480,000 | +2.2% | 91,810 | -8.0% | 0.01% | 0.0% |
| Q2 2022 | $9,276,000 | -48.0% | 99,782 | -34.3% | 0.01% | -35.3% |
| Q1 2022 | $17,834,000 | -14.3% | 151,959 | -1.7% | 0.02% | 0.0% |
| Q4 2021 | $20,801,000 | +297.6% | 154,620 | +371.0% | 0.02% | +240.0% |
| Q3 2021 | $5,232,000 | +181.7% | 32,827 | +132.5% | 0.01% | +150.0% |
| Q2 2021 | $1,857,000 | -11.9% | 14,117 | -13.7% | 0.00% | 0.0% |
| Q1 2021 | $2,109,000 | -44.1% | 16,367 | -27.6% | 0.00% | -33.3% |
| Q4 2020 | $3,771,000 | +49.3% | 22,608 | +38.1% | 0.00% | 0.0% |
| Q3 2020 | $2,525,000 | -15.2% | 16,365 | -18.8% | 0.00% | -25.0% |
| Q2 2020 | $2,979,000 | +32.3% | 20,146 | +0.7% | 0.00% | 0.0% |
| Q1 2020 | $2,252,000 | +619.5% | 19,999 | +789.2% | 0.00% | – |
| Q4 2019 | $313,000 | -78.1% | 2,249 | -84.8% | 0.00% | -100.0% |
| Q3 2019 | $1,428,000 | -27.0% | 14,822 | -12.7% | 0.00% | 0.0% |
| Q2 2019 | $1,956,000 | -93.6% | 16,985 | -93.4% | 0.00% | -94.9% |
| Q1 2019 | $30,387,000 | +950.4% | 258,177 | +459.1% | 0.04% | +875.0% |
| Q4 2018 | $2,893,000 | +1.3% | 46,181 | +14.6% | 0.00% | +33.3% |
| Q3 2018 | $2,856,000 | +115.5% | 40,300 | +102.3% | 0.00% | +50.0% |
| Q2 2018 | $1,325,000 | +266.0% | 19,923 | +259.5% | 0.00% | – |
| Q1 2018 | $362,000 | – | 5,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |